Products

What will AGI do for Apramycin?

This classification denotes an antibiotic with the molecular formula C21H41N5O11, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 388K3TR36Z, chemically known as 4-o-((8r)-2-amino-8-o-(4-amino-4-deoxy-alpha-d-glucopyranosyl)-2,3,7-trideoxy-7-(methylamino)-d-glycero-alpha-d-allo-octodialdo-1,5:8,4-dipyranos-1-yl)-2-deoxy-d-streptamine but generally known as apramycin, which bears US NIH Compound Identifier 71428. Apramycin most often comes in base and sulphate forms. European Medicines Agency schedules Apramycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05540MIG. The term APRAMYCIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). APRAMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule apramycin under HS 29419000 and SITC 54139. As of Q4 2014, APRAMYCIN remains the US FDA Preferred Term for this commodity. Apramycin bears US NLM identifiers UMLS ID C0052231 and NCI Concept Code C78789. SMILES: O1C2C(OC(OC3OC(C(N)C(O)C3O)CO)C(NC)C2O)CC(N)C1OC1C(N)CC(N)C(O)C1O.